Quanta Inc (fka QNTA)

[JediMozart]

“the Company has renewed a product registration certificate for its lead drug candidate Escozine® from the Ministry of Health in the Dominican Republic (DR). The registration enables Escozine® to be prescribed as a natural bioactive alternative medicine to be used in cancer treatments as well as a treatment for the SARS-CoV-2 (COVID-19) virus, after Medolife performed a safety and efficacy study on COVID-19. This registration in the DR through in-place trade agreements opens the door for distribution and sales in most of Latin America.”

“This registration not only validates Escozine® as a cancer therapeutic but creates an unbelievable revenue generation opportunity for our company in that the product can be off-label prescribed for treatment of COVID-19 patients as a supportive therapy where vaccination progression has been slow,” said Medolife CEO Dr. Arthur Mikaelian. “Through free trade agreements, we will be able to market Escozine to one of the largest populations in the world.

https://www.einnews.com/pr_news/540212003/medolife-rx-announces-historic-product-registration-in-dominican-republic-enabling-escozine-to-be-sold-throughout-latin-america-as-natural-alternative